King FL - Search Results

1

Maternal reproductive history and birth characteristics in childhood acute lymphoblastic leukemia.

Kaye SA, Robison LL, Smithson WA, Gunderson P, King FL, Neglia JP. Kaye SA, et al. Among authors: king fl. Cancer. 1991 Sep 15;68(6):1351-5. doi: 10.1002/1097-0142(19910915)68:6<1351::aid-cncr2820680627>3.0.co;2-j. Cancer. 1991. PMID: 1873786

2

Birth weight as a risk factor for childhood acute lymphoblastic leukemia.

Robison LL, Codd M, Gunderson P, Neglia JP, Smithson WA, King FL. Robison LL, et al. Among authors: king fl. Pediatr Hematol Oncol. 1987;4(1):63-72. doi: 10.3109/08880018709141250. Pediatr Hematol Oncol. 1987. PMID: 3152913

3

Prenatal and perinatal risk factors for neuroblastoma. A case-control study.

Neglia JP, Smithson WA, Gunderson P, King FL, Singher LJ, Robison LL. Neglia JP, et al. Among authors: king fl. Cancer. 1988 Jun 1;61(11):2202-6. doi: 10.1002/1097-0142(19880601)61:11<2202::aid-cncr2820611113>3.0.co;2-7. Cancer. 1988. PMID: 3365650

4

Cytotoxic chemotherapy for pregnancy-associated breast cancer: single institution case series.

Morris PG, King F, Kennedy MJ. Morris PG, et al. J Oncol Pharm Pract. 2009 Dec;15(4):241-7. doi: 10.1177/1078155209103096. J Oncol Pharm Pract. 2009. PMID: 19304882

5

Introduction of a dose-banding system for parenteral chemotherapy on a haematology-oncology day ward.

O'Leary CE, Collins A, Henman MC, King F. O'Leary CE, et al. J Oncol Pharm Pract. 2019 Mar;25(2):351-361. doi: 10.1177/1078155217736376. Epub 2017 Oct 23. J Oncol Pharm Pract. 2019. PMID: 29059028

6

Identification of risks associated with the prescribing and dispensing of oral anticancer medicines in Ireland.

Hammond L, Marsden E, O'Hanlon N, King F, Henman MC, Keane C. Hammond L, et al. Int J Clin Pharm. 2012 Dec;34(6):893-901. doi: 10.1007/s11096-012-9688-1. Epub 2012 Sep 9. Int J Clin Pharm. 2012. PMID: 22961608

7

Clinical utility of anti-interleukin 5 monoclonal therapy in asthma using a national, centralised, outcome-based system of drug access.

O'Leary C, Schultz C, Walsh C, Adams R, Casey D, Lane S, Harrison M, Doyle S, Costello RW, King F, Murphy DM. O'Leary C, et al. BMJ Open Respir Res. 2022 Sep;9(1):e001341. doi: 10.1136/bmjresp-2022-001341. BMJ Open Respir Res. 2022. PMID: 36167473 Free PMC article.

8

Mass-spectrometric characterization of cisplatin binding sites on native and denatured ubiquitin.

Zhao T, King FL. Zhao T, et al. Among authors: king fl. J Biol Inorg Chem. 2011 Apr;16(4):633-9. doi: 10.1007/s00775-011-0767-x. Epub 2011 Mar 2. J Biol Inorg Chem. 2011. PMID: 21365334

9

Improved expression of secreted and membrane-targeted proteins in insect cells.

Hitchman RB, Possee RD, Siaterli E, Richards KS, Clayton AJ, Bird LE, Owens RJ, Carpentier DC, King FL, Danquah JO, Spink KG, King LA. Hitchman RB, et al. Among authors: king fl. Biotechnol Appl Biochem. 2010 Jun 21;56(3):85-93. doi: 10.1042/BA20090130. Biotechnol Appl Biochem. 2010. PMID: 20441568

10

A mass spectrometric comparison of the interactions of cisplatin and transplatin with myoglobin.

Zhao T, King FL. Zhao T, et al. Among authors: king fl. J Inorg Biochem. 2010 Feb;104(2):186-92. doi: 10.1016/j.jinorgbio.2009.10.019. Epub 2009 Oct 29. J Inorg Biochem. 2010. PMID: 19945168

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters